Short term swing trade | Buy NSE: VENUSREM | 9-11% target | Indian stock trading calls on 10 Jun 2025

NOTE

Closing Price: ₹442.70 (as of Jun 09, 2025)
StopLoss*: Apply on the daily close. After the first target, reset the StopLoss to your buying price.
Duration^: Approximate holding period based on the active trading days (excluding market holidays). Actual holding may vary with the market conditions.
Upside Potential#: Based on median of the suggested buy range.

Venus Remedies Limited is a pharmaceutical company based in Panchkula, India, founded in 1989. It operates in India and internationally, focusing on research and development in antimicrobial resistance and oncology. The company also makes a wide range of medicines, including antibiotics, antivirals, pain relievers, heart medicines, disinfectants, hormone therapies, supplements, herbal medicines, and more.

Technical Analysis

Key Observations

The stock recently broke above a long-term trendline resistance, supported by strong trading volumes – a bullish technical signal indicating renewed upward momentum.

Technical Image - Daily Timeframe

Technical Analysis

Key Observations

The stock recently broke above a long-term trendline resistance, supported by strong trading volumes – a bullish technical signal indicating renewed upward momentum.

Technical Image - Daily Timeframe

Conclusion

Venus Remedies Stock Price Forecast

Based on our swing trading stock selection for indian stock market, the Venus Remedies Stock Price target will be INR 470 - INR 480 in the next 12-14 trading sessions.

Conclusion

Venus Remedies Stock Price Forecast

Based on our swing trading stock selection for indian stock market, the Venus Remedies Stock Price target will be INR 470 - INR 480 in the next 12-14 trading sessions.

Analyst Summary

The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.